Dr. Enver Akalin, MD

Dr. Akalin practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Akalin's NPI, 1407885205, was assigned on July 2, 2006. Dr. Akalin holds New York license 237443.

Dr. Akalin's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Akalin's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Akalin to 1 more school health center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akalin practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Akalin's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Akalin is licensed in New York.

CMS data shows 275 Medicare services from Dr. Akalin across 5 procedure codes in 2024, for 102 Medicare patients. Medicare paid $24,690 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 102 Medicare patients who saw Dr. Akalin in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 51% are also on Medicaid. Their average risk score is 5.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akalin's median patient age at 61, with 39% women.

In 2024, Dr. Akalin wrote 3,455 Medicare Part D claims for 147 patients. 86% of them were for generic drugs. CMS names the drug for 3,185 of them, across 68 drugs with 11 or more claims each, at $261,407 in total drug cost. In 2023, CMS named 3,287 claims across 59 drugs.

CMS lists Dr. Akalin as offering telehealth.

Dmand AI links 97 papers to Dr. Akalin, published from 2011 to 2025. 2020 was the busiest year, with 19. The most frequent topics are Kidney Transplantation, Graft Survival and Graft Rejection. Dr. Akalin has published most often in Transplantation. Dr. Akalin's most frequent co-authors are Maria Ajaimy, MD, Jonathan Scott Bromberg, MD and Layla G. Kamal, MD.

Dmand AI links Dr. Akalin to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Delayed Graft Function and Pathological Conditions, Signs and Symptoms.

CMS Open Payments shows 74 general payments to Dr. Akalin from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. Immucor, Inc. paid the most, $49,500. It also lists 1 research payment totaling $754 in 2016.